as on January 22, 2026 at 11:42 pm IST
Day's Low
Day's High
4.37%
Downside
1.68%
Upside
52 Week's Low
52 Week's High
43.17%
Downside
9.41%
Upside
Check Mannkind Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
0.1933
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.35%
PE Ratio (TTM)
50.7
Industry PE ratio
-1.4026293103448275
PEG Ratio
-0.23
EBITDA
84.7M
Revenue (TTM)
313.8M
Profit Margin
9.32%
Return On Equity TTM
0.00%
Track how Mannkind Corp. P/E has moved over time to understand its valuation trends.
Mannkind Corp. in the last 5 years
Lowest (-83.58x)
December 31, 2023
Industry (-1.40x)
January 22, 2026
Today (50.70x)
January 22, 2026
Highest (114.51x)
March 31, 2024
Today’s Price to Earnings Ratio: 50.70x
Compare market cap, revenue, PE, and other key metrics of Mannkind Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.6B | 61.3% | 50.7 | 9.32% | |
| BUY | $47.0B | 112.01% | 1269.75 | 1.36% | |
| BUY | $113.3B | 94.09% | 31.15 | 31.35% | |
| NA | $37.0B | NA | 619.04 | 1.38% | |
| BUY | $77.8B | 39.34% | 17.58 | 32.13% |
The Mannkind Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mannkind Corp. investment value today
Current value as on today
₹1,02,347
Returns
₹2,347
(+2.35%)
Returns from Mannkind Corp. Stock
Dollar Returns*
₹5,913 (+5.91%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Mannkind Corp.. Average target price of $9.44
Get share price movements and forecasts by analysts on Mannkind Corp..
What analysts predicted
36.97%UPSIDE
Target Price
$9.44
Current Price
$5.95
Analyzed by
12 Analysts
Target
$9.44
Mannkind Corp. target price $9.44, a slight upside of 36.97% compared to current price of $5.95. According to 12 analysts rating.
Search interest for Mannkind Corp. Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:45% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 01 December
Mon, 06:35 PM
-MannKind's FUROSCIX ReadyFlow Autoinjector sNDA accepted by FDA for review, targeting chronic heart failure and kidney disease treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 76.52M → 82.13M (in $), with an average increase of 6.8% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 668.0K → 7.98M (in $), with an average increase of 91.6% per quarter
Price Rise
![]()
In the last 6 months, MNKD stock has moved up by 45.3%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 28.2% return, outperforming this stock by 8.0%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 53.7% return, outperforming this stock by 61.2%
| Organisation | Mannkind Corp. |
| Headquarters | 1 Casper Street, Danbury, CT, United States, 06810 |
| Industry | Health Technology |
| CEO | Dr. Michael E. Castagna Pharm.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Sanjay Singh M.B.A. | Executive Vice President of Technical Operations |
Ms. Rosabel Realica Alinaya CPA | VP of Investor Relations & Treasury |
Dr. Stuart A. Tross Ph.D. | Executive Vice President of Human Resources |
Mr. John F. Bedard | Senior Vice President of Worldwide Regulatory Affairs |
Mr. Dominic Marasco R.Ph. | President of Endocrine Business Unit |
Dr. Michael E. Castagna Pharm.D. | CEO & Director |
Mr. Christopher B. Prentiss M.B.A. | Chief Financial Officer |
Dr. David B. Thomson J.D., Ph.D. | Executive VP, General Counsel & Secretary |
Dr. Kevin Kaiserman M.D. | Senior VP & Therapeutic Area Head of Endocrine Diseases |
Dr. Ajay Ahuja M.B.A., M.D. | Chief Medical Officer |
Mannkind Corp. share price today is $5.95 as on . Mannkind Corp. share today touched a day high of $6.05 and a low of $5.69.
Mannkind Corp. share touched a 52 week high of $6.51 on and a 52 week low of $3.38 on . Mannkind Corp. stock price today i.e. is trending at $5.95,which is 8.60% down from its 52 week high and 75.97% up from its 52 week low.
Mannkind Corp. market capitalisation is $0.00T as on .
Indian investors can start investing in Mannkind Corp. (MNKD) shares with as little as ₹91.567 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.67 in Mannkind Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mannkind Corp. share’s latest price of $5.95 as on January 22, 2026 at 11:42 pm IST, you will get 1.6807 shares of Mannkind Corp.. Learn more about
fractional shares .
Mannkind Corp. stock has given 61.3% share price returns and 24.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?